6. Results of univariate meta‐regression analysis for CABG.
Explanatory variable (n trials) | Exp(slope)* |
95% Confidence interval Univariate P value |
Proportion of variation explained | Interpretation |
Case mix (% MI patients) (n = 28) |
RR = 1.009 | 1.000 to 1.018 P = 0.28 |
0% | No evidence that risk ratio is associated with case mix |
Dose of exercise (dose =number of weeks of exercise training x average number of sessions/week x average duration of session in min) (n= 23) | RR = 1.000 | 1.000 to 1.000 P = 0.93 |
0% | No evidence that risk ratio is associated with increased dose of exercise |
Type of CR (exercise only vs CR rehab) (n = 28) |
RR = 1.027 | 0.659 to 1.600 P = 0.27 |
0% | No evidence that risk ratio is associated with type of CR |
Duration of follow‐up (months) (n = 28) | RR = 0.999 | 0.991 to 1.007 P = 0.98 |
0% | No evidence of a change in risk ratio with longer follow‐up |
Year of publication (pre 1995 vs post 1995) (n = 28) |
RR = 0.997 | 0.979 to 1.016 P = 1.00 |
0% | No evidence that risk ratio is associated with year of publication |
Setting (centre vs home) (n = 28) | RR = 1.090 | 0.876 to 1.357 P = 0.76 |
0% | No evidence that risk ratio is associated with setting |
Risk of bias (low risk in ≥ 5 items v < 5 items) (n = 28) | RR = 0.981 | 0.882 to 1.091 P = 0.79 |
0% | No evidence that risk ratio is associated with risk of bias |
Study location (n = 28) | RR = 1.199 | 0.819 to 1.754 P = 1.00 |
0% | No evidence that risk ratio is associated with study location |
Sample size (n = 28) | RR = 1.000 | 1.000 to 1.001 P = 1.00 |
0% | No evidence that risk ratio is associated with sample size |
P‐values adjusted for multiple testing